Assyro AI

Orange Book product · Brand (NDA)

BREVITAL SODIUM

METHOHEXITAL SODIUM

Brand (NDA)NDA 011559DISCN PH HEALTH

At a glance

Dec 21, 2012

Approved

Brand (NDA)

Application

Not listed

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Dec 21, 2012

    13 yr 8 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

METHOHEXITAL SODIUM

Strength

200MG/VIAL

Dosage form

INJECTABLE

Route

INJECTION

TE code

Not listed

Application

NDA 011559

Product number

004

Marketing status

DISCN

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

This is a brand (NDA) product. Other products sharing this active ingredient are listed below.

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.